MedPath

High Intensity Body-weight Circuit Training Feasibility and Efficacy for in Middle Aged Persons With Type 2 Diabetes

Not Applicable
Recruiting
Conditions
Type2diabetes
Registration Number
NCT05571384
Lead Sponsor
Kennesaw State University
Brief Summary

This research study proposes to quantify the efficacy of the novel high intensity body-weight circuit (HIBC) training intervention on metabolic profile, body composition, and health related fitness exercise in middle aged persons with type-2 diabetes (T2DM). This research project is extremely relevant to public health, in that prevalence of T2DM continues to rise on a national and global scale, placing a heavy economic cost on both the healthcare industry and the individual patient in an age-dependent fashion. Results of this study may provide an effective and appealing alternative exercise intervention for cardiometabolic disease management in adults with T2DM, and have significant clinical and public health applications.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Recent diagnosed of type 2 diabetes (T2DM) (within a year) * HbA1c of 6% or higher

    • Non-insulin dependent
    • No medicinal treatment
    • Not currently undergoing a physical activity program in the last six months
    • Received written medical clearance from overseeing physician
Exclusion Criteria
  • Those who have undergone any revascularization procedure

    • Diagnosed with or symptomatic of any renal, pulmonary, or cardiovascular disease (CVD)
    • Diagnosed cognitive dysfunction
    • Current smoker

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
HbA1c change within participantPre and post 16-week intervention

HbA1c (glycosylated Hemoglobin) indicates what the blood glucose environment was like for that past 3-months. This is the average life span of a red blood cell. High levels of blood glucose over a 3 month period lead to high HbA1c and vis versa. HbA1c can change as early as 14 weeks.

Oral Glucose Tolerance Test change within participantPre and post 16-week intervention

Glucose and Insulin response to bolus amount of glucose beverage

Body Composition change within participantPre and post 16-week intervention

Fat mass and lean mass

Estimated VO2max (oxygen consumption), aerobic exercise capacity change within participantPre and post 16-week intervention

sub maximal treadmill endurance test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kennesaw State Univeristy

🇺🇸

Kennesaw, Georgia, United States

Kennesaw State Univeristy
🇺🇸Kennesaw, Georgia, United States
Brian Kliszczewicz, Ph.D.
Contact
315-415-6609
Bkliszcz@kennesaw.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.